Please wait while the formulary information is being retrieved.
VENTAVIS (ILOPROST)
- Pulmonary arterial hypertension
10 mcg/mL solution for nebulization
- Inhale 0.5 milliliter (5 mcg) via nebulizer by inhalation route 6 times per day
20 mcg/mL solution for nebulization
- Inhale 0.25 milliliter (5 mcg) via nebulizer by inhalation route 6 times per day
Pulmonary arterial hypertension
- Inhale 0.5 milliliter (5 mcg) via nebulizer by inhalation route 6 times per day
- Inhale 0.5 milliliter (5 mcg) via nebulizer by inhalation route 9 times per day
- Inhale 0.25 milliliter (5 mcg) via nebulizer by inhalation route 6 times per day
- Inhale 0.25 milliliter (5 mcg) via nebulizer by inhalation route 9 times per day
- Inhale 0.25 milliliter (5 mcg) via nebulizer by inhalation route every 2 hours during waking hours
- Inhale 0.125 milliliter (2.5 mcg) via nebulizer by inhalation route every 2 hours during waking hours
- Inhale 0.125 milliliter (2.5 mcg) via nebulizer by inhalation route 6Times per day
- Inhale 0.125 milliliter (2.5 mcg) via nebulizer by inhalation route 9Times per day
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Hypotension
- Pulmonary edema
- Severe hepatic disease
Severe
Moderate
- Bronchospastic pulmonary disease
- Chronic obstructive pulmonary disease
VENTAVIS (ILOPROST)
- Pulmonary arterial hypertension
- None
- Back pain
- Cough
- Cramps
- Flu-like symptoms
- Headache disorder
- Hypotension
- Insomnia
- Nausea
- Palpitations
- Syncope
- Trismus
- Vasodilation of blood vessels
- Vomiting
More Frequent
Severe
Less Severe
- Pneumonia
- Hemoptysis
- Sore tongue
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Bronchospastic pulmonary disease
- Chest pain
- Chronic heart failure
- Dyspnea
- Hypersensitivity drug reaction
- Paroxysmal supraventricular tachycardia
- Peripheral edema
- Renal failure
- Thrombocytopenic disorder
Less Severe
- Diarrhea
- Dizziness
- Epistaxis
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Iloprost (Inh, Inj)
No safety and efficacy information available.
- 1 Day – 18 Years
- No safety and efficacy information available.
Iloprost Trometamol (inh)
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Iloprost Trometamol (inh)
Insuff. human data;Higher mortality in pups of lactating dams in rat studies
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insuff. human data;Higher mortality in pups of lactating dams in rat studies |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Pulmonary arterial hypertension | |
| I27.0 | Primary pulmonary hypertension |
| I27.21 | Secondary pulmonary arterial hypertension |
| 0-9 | A-Z |
|---|---|
| I27.0 | Primary pulmonary hypertension |
| I27.21 | Secondary pulmonary arterial hypertension |
Formulary Reference Tool